l carnitine and prostate health Full article: Effects of L-Carnitine Coenzyme Q10 Supplementation on Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A Randomized, Controlled, Clinical Trial L-Carnitine | Linus Pauling Institute

Treatment starts at 0.25 mg weekly and increases every four weeks through 0.5 mg, 1.0 mg, and 1.7 mg before reaching the maintenance dose of 2.4 mg per week

Therapeutic Potential Due to its high affinity for the IGF-1 receptor and the benefits that activation of this receptor can provide, it has been investigated for its ability to treat: Wounds and Injuries: IGF-1 LR3 supports the regeneration of tendons and nerves after injury, potentially speeding recovery and reducing scar formation

And also studies performed on breast cancer cells showed that ALA can inhibit migration and invasion of metastatic cancer cells

Codeage Liposomal TUDCA+ is manufactured in the USA with global ingredients in a cGMP-certified facility for quality and purity

Protocols, doses, and reactions reported below come from clinical trials and community sources